Subcutaneous ICD implantation is a viable and safe alternative for young patients with Brugada syndrome who experience transvenous ICD lead complications.
Answers are grounded in this paper and cite their sources.
May support considering Brugada in nonspecific symptoms; hypothesis-generating case report leaves optimal screening open.
Brugada syndrome is an arrhythmogenic condition characterized by ST-segment elevation and J-point elevation in at least two precordial leads. Most ST segment elevations are associated with myocardial infarction, although other conditions such as pericarditis, channelopathies, and a few genetic conditions should be considered. Brugada syndrome is an inherited cardiac condition associated with an increased risk of sudden cardiac death (SCD). The most common presentation is palpitations or syncopal events in patients presenting to the emergency department. We present the case of a young 26-year-old patient who was diagnosed with Brugada syndrome at the age of 11 following a syncopal event at school and had a transvenous implantable cardioverter defibrillator (ICD) implanted. He was found to have a high lead impedance following a collapse at his routine outpatient device clinic appointment and was transferred to our hospital. He underwent successful transvenous ICD and lead extraction and had a subcutaneous ICD implanted.
No takes yet. Share an insight, caveat, or question.
Zahid Khan (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: